Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011236
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Shanghai Fosun Pharmaceutical (Group) Co Ltd (Fosun Pharma), a subsidiary of Shanghai Fosun High Technology (Group) Co Ltd is a drug company that offers pharmaceutical products, medical diagnostic products and medical device products. The company’s pharmaceutical products include metabolism and digestive system, cardiovascular system, blood system, central nervous system drugs, anti-infection, anti-tumor, vaccine and raw material and intermediates. It provides medical diagnostic products such as real time PCR detector, human papillomavirus genotyping kit, HBV quantitative reagent, and biofosun microorganism identification and susceptibility analysis system. The company’s research and development unit concentrates on therapeutic areas of metabolism and digestive system, blood system, cardiovascular system and central nervous system. Fosun Pharma is headquartered in Shanghai, China.

Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deal Details 13
Venture Financing 13
Paragon Genomics Raises USD8 Million in Series A Financing 13
Spirometrix Raises USD17.4 Million in Series C Financing 14
Check-Cap Raises Funds through Venture Financing 15
Saladax Biomedical Raises US$23 Million In Series D Venture Financing 16
Private Equity 18
Healthy Harmony and Shanghai Fosun Pharma Acquire Chindex International in Going Private Transaction for USD461 Million 18
PBM Capital Acquires Breas Medical From GE Healthcare 20
KKR Receives Government Approval To Acquire 35% Stake In Gland Pharma For USD200 Million 21
Partnerships 22
Intuitive Surgical to Form Joint Venture with Shanghai Fosun Pharma 22
Astute Medical Enters into Distribution Agreement with Fosun Long March 23
CareFusion Enters into Distribution Agreement with Breas Medical for Vivo Line of Ventilators 24
Miacom Diagnostics Enters into Co-Marketing Agreement with Fosun Diagnostics 25
Litha Pharma Partners with Gland Pharma 26
Equity Offering 27
Shanghai Fosun Pharma to Raise USD298.3 Million in Private Placement of Shares 27
Chindex to Raise USD38.2 Million in Private Placement of Shares 29
Debt Offering 30
Shanghai Fosun Pharma Plans to Raise up to USD1 Billion in Private Placement of Bonds 30
Shanghai Fosun Pharma Raises USD65.3 Million in First Tranche of Private Placement of 3.95% Notes Due 2018 31
Acquisition 32
Shanghai Fosun Pharma to Acquire 65% Stake in SinoMedCare Biotech for USD40 Million 32
Fosun Pharma Acquires 80% stake in Breas Medical 33
Breas Medical Acquires B&D Electromedical 34
Shanghai Fosun Pharma Acquires 37% Stake in miacom diagnostics 35
Shanghai Fosun to Acquire 35% Stake in Sinopharm Holding Medical Investment Management from Sinopharm Group for up to USD32.4 Million 36
Fosun Pharma And Pramerica-Fosun China Opportunity Fund Complete Acquisition Of 95.6% Stake In Alma Lasers For US$250 Million 37
Shanghai Fosun Pharma Acquires 17.65% Stake In SD Biosensor, In Vitro Diagnostics Company 39
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Key Competitors 40
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Key Employees 41
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Locations And Subsidiaries 43
Head Office 43
Other Locations & Subsidiaries 43
Joint Venture 44
Recent Developments 45
Corporate Communications 45
Jun 29, 2016: Shanghai Fosun Pharmaceutical (Group) Announces Resignation Of Non-Executive Director 45
Jun 07, 2016: Shanghai Fosun Pharmaceutical Announces Management Changes, Names New President and CEO 46
Mar 02, 2016: Resignation Of Non-Executive Director: Shanghai Fosun Pharmaceutical 48
Legal and Regulatory 49
Sep 05, 2017: Fosun Pharmas Subsidiary Sisram, the World’s Leading Energy-Based Medical Aesthetic Treatment Systems Provider, to be Listed as the First Israeli Company on the Main Board of SEHK 49
Appendix 51
Methodology 51
About GlobalData 51
Contact Us 51
Disclaimer 51

List of Tables
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Key Facts, 2016 2
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Deals By Market, 2011 to YTD 2017 9
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Paragon Genomics Raises USD8 Million in Series A Financing 13
Spirometrix Raises USD17.4 Million in Series C Financing 14
Check-Cap Raises Funds through Venture Financing 15
Saladax Biomedical Raises US$23 Million In Series D Venture Financing 16
Healthy Harmony and Shanghai Fosun Pharma Acquire Chindex International in Going Private Transaction for USD461 Million 18
PBM Capital Acquires Breas Medical From GE Healthcare 20
KKR Receives Government Approval To Acquire 35% Stake In Gland Pharma For USD200 Million 21
Intuitive Surgical to Form Joint Venture with Shanghai Fosun Pharma 22
Astute Medical Enters into Distribution Agreement with Fosun Long March 23
CareFusion Enters into Distribution Agreement with Breas Medical for Vivo Line of Ventilators 24
Miacom Diagnostics Enters into Co-Marketing Agreement with Fosun Diagnostics 25
Litha Pharma Partners with Gland Pharma 26
Shanghai Fosun Pharma to Raise USD298.3 Million in Private Placement of Shares 27
Chindex to Raise USD38.2 Million in Private Placement of Shares 29
Shanghai Fosun Pharma Plans to Raise up to USD1 Billion in Private Placement of Bonds 30
Shanghai Fosun Pharma Raises USD65.3 Million in First Tranche of Private Placement of 3.95% Notes Due 2018 31
Shanghai Fosun Pharma to Acquire 65% Stake in SinoMedCare Biotech for USD40 Million 32
Fosun Pharma Acquires 80% stake in Breas Medical 33
Breas Medical Acquires B&D Electromedical 34
Shanghai Fosun Pharma Acquires 37% Stake in miacom diagnostics 35
Shanghai Fosun to Acquire 35% Stake in Sinopharm Holding Medical Investment Management from Sinopharm Group for up to USD32.4 Million 36
Fosun Pharma And Pramerica-Fosun China Opportunity Fund Complete Acquisition Of 95.6% Stake In Alma Lasers For US$250 Million 37
Shanghai Fosun Pharma Acquires 17.65% Stake In SD Biosensor, In Vitro Diagnostics Company 39
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Key Competitors 40
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Key Employees 41
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Subsidiaries 43
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Joint Venture 44

★海外企業調査レポート[Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Old Mutual Plc:企業のM&A・事業提携・投資動向
    Old Mutual Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Old Mutual Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Bayshore Petroleum Corp (BSH):企業の財務・戦略的SWOT分析
    Summary Bayshore Petroleum Corp (Bayshore Petroleum) is an oil and gas company that explores, produces, and develops natural gas and petroleum. The company develops conventional and unconventional oil and gas prospects in North America and across the world. It utilizes CCC technology for heavy oil a …
  • Key Energy Services, Inc.:企業の戦略・SWOT・財務情報
    Key Energy Services, Inc. - Strategy, SWOT and Corporate Finance Report Summary Key Energy Services, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Carlisle Coatings & Waterproofing Inc:企業の戦略的SWOT分析
    Carlisle Coatings & Waterproofing Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Mehler Vario System GmbH:企業の戦略・SWOT・財務情報
    Mehler Vario System GmbH - Strategy, SWOT and Corporate Finance Report Summary Mehler Vario System GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Fluor Corporation (FLR)-石油・ガス分野:企業M&A・提携分析
    Summary Fluor Corporation (Fluor) is a global provider of engineering and construction services. Its service portfolio includes design, engineering, procurement, fabrication, modularization, construction, commissioning and maintenance, and project management solutions. It also offers other services …
  • Euro-Diagnostica AB-医療機器分野:企業M&A・提携分析
    Summary Euro-Diagnostica AB (Euro Diagnostica) is a medical device company that manufactures and markets purified reagents and antibodies. The company offers blood based solutions, developed to aid clinicians in diagnosis, prognosis, monitoring and treatment of autoimmune diseases. It offers product …
  • IMCO Industries Ltd.:企業の戦略・SWOT・財務情報
    IMCO Industries Ltd. - Strategy, SWOT and Corporate Finance Report Summary IMCO Industries Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Lisi Aerospace SAS:戦略・SWOT・企業財務分析
    Lisi Aerospace SAS - Strategy, SWOT and Corporate Finance Report Summary Lisi Aerospace SAS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Staatsolie Maatschappij Suriname NV:企業の戦略的SWOT分析
    Staatsolie Maatschappij Suriname NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • SciBase AB (SCIB):企業の財務・戦略的SWOT分析
    Summary SciBase AB (SciBase) is a medical technology company that offers non-invasive detection and monitoring of skin tissue alterations. The company develops point of care device for the accurate detection of malignant melanoma. It offers electrical impedance spectroscopy which uses the varying el …
  • Fluor Corp (FLR):電力:M&Aディール及び事業提携情報
    Summary Fluor Corp (Fluor) is a provider of engineering and construction services. The company's service portfolio includes design, engineering, procurement, fabrication, modularization, construction, commissioning and maintenance, and project management solutions. Fluor also offers other services t …
  • Einstein Noah Restaurant Group, Inc. (Foodservice):戦略・SWOT・企業財務分析
    Einstein Noah Restaurant Group, Inc. (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary Einstein Noah Restaurant Group, Inc. (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's struct …
  • Nippon Seiro Co., Ltd. (5010):企業の財務・戦略的SWOT分析
    Nippon Seiro Co., Ltd. (5010) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Nippon Paper Industries Co., Ltd.:企業の戦略・SWOT・財務情報
    Nippon Paper Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nippon Paper Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Borealis AG:企業の戦略的SWOT分析
    Borealis AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Statoil ASA (STL)-エネルギー分野:企業M&A・提携分析
    Summary Statoil ASA (Statoil) is an independent upstream oil and gas company. The company explores for, develops and produces oil and gas from its assets across the world, and trades crude oil and natural gas. The company operates assets in Norwegian Continental Shelf (NCS), which includes the North …
  • First Solar Inc (FSLR):企業の財務・戦略的SWOT分析
    First Solar Inc (FSLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Atomstroyexport:企業の戦略的SWOT分析
    Atomstroyexport - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • hVIVO Plc (HVO):製薬・医療:M&Aディール及び事業提携情報
    Summary hVIVO Plc (hVIVO), formerly Retroscreen Virology Ltd is a biopharma company that develops human-based analytical platform to accelerate drug discovery and development. The company enables organisations to discover drugs and diagnostics and accelerate new product development. It uses human di …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆